| Gross Sales | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Operating Income | 1.32 | 1.33 | 1.32 | 5.90 |
| Other Income | 210.76 | 52.30 | 87.68 | 95.30 |
| Total Income | 212.08 | 53.63 | 89.00 | 101.20 |
| Total Expenditure | 24.56 | 23.83 | 26.00 | 20.26 |
| PBIDT | 187.52 | 29.80 | 63.00 | 80.94 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDT | 187.52 | 29.80 | 63.00 | 80.94 |
| Depreciation | 0.19 | 0.17 | 0.15 | 0.08 |
| Tax | 38.78 | -6.30 | 1.72 | 10.33 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 148.55 | 35.93 | 61.13 | 70.53 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 148.55 | 35.93 | 61.13 | 70.53 |
| | | | |
| EPS (Unit Curr.) | 0.62 | 0.14 | 0.26 | 0.29 |
| EPS (Adj) (Unit Curr.) | 0.62 | 0.14 | 0.26 | 0.29 |
| Calculated EPS (Unit Curr.) | 0.62 | 0.15 | 0.26 | 0.29 |
| Calculated EPS (Adj) (Unit Curr.) | 0.62 | 0.15 | 0.26 | 0.29 |
| Calculated EPS (Ann.) (Unit Curr.) | 2.48 | 0.60 | 1.02 | 1.18 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 2.48 | 0.60 | 1.02 | 1.18 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 2396.80 | 2396.80 | 2396.80 | 2396.80 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | |
| Public Shareholding (No Of.Shares) | 364800000.00 | 364800000.00 | 364800000.00 | 364800000.00 |
| Public Shareholding (% in Equity) | 15.22 | 15.22 | 15.22 | 15.22 |
| | | | |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| | | | |
| Non Encumbered - No. of Shares | 2032000000.00 | 2032000000.00 | 2032000000.00 | 2032000000.00 |
| Non Encumbered - % in Total Promoters Holding | 100.00 | 100.00 | 100.00 | 100.00 |
| Non Encumbered - % in Total Equity | 84.78 | 84.78 | 84.78 | 84.78 |
| | | | |
| PBIDTM(%) | NA | NA | NA | NA |
| PBDTM(%) | NA | NA | NA | NA |
| PATM(%) | NA | NA | NA | NA |